IS2742A7 - Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra - Google Patents

Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra

Info

Publication number
IS2742A7
IS2742A7 IS2742A IS2742A IS2742A7 IS 2742 A7 IS2742 A7 IS 2742A7 IS 2742 A IS2742 A IS 2742A IS 2742 A IS2742 A IS 2742A IS 2742 A7 IS2742 A7 IS 2742A7
Authority
IS
Iceland
Prior art keywords
pyrrolidin
production
substances derived
substances
derived
Prior art date
Application number
IS2742A
Other languages
English (en)
Inventor
Aschwanden Werner
Kyburz Emilio
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of IS2742A7 publication Critical patent/IS2742A7/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IS2742A 1981-07-24 1982-06-22 Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra IS2742A7 (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4849/81A CH647234A5 (en) 1981-07-24 1981-07-24 Pyrrolidine derivatives

Publications (1)

Publication Number Publication Date
IS2742A7 true IS2742A7 (is) 1983-01-25

Family

ID=4283624

Family Applications (1)

Application Number Title Priority Date Filing Date
IS2742A IS2742A7 (is) 1981-07-24 1982-06-22 Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra

Country Status (10)

Country Link
JP (1) JPS5824558A (is)
KR (1) KR890000768B1 (is)
BR (1) BR8204328A (is)
CH (1) CH647234A5 (is)
ES (1) ES8404678A1 (is)
GR (1) GR76177B (is)
IS (1) IS2742A7 (is)
MW (1) MW2682A1 (is)
PL (1) PL138918B1 (is)
ZA (1) ZA825104B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666891A5 (de) * 1985-11-26 1988-08-31 Lonza Ag 4-alkoxy-2-oxo-pyrrolidin-1-yl-essigsaeure-c(1)-c(4)-alkylester, deren herstellung und verwendung.
KR100498268B1 (ko) * 1997-12-09 2005-11-01 주식회사 엘지생활건강 피롤리돈계 양쪽성 계면활성제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
ES520820A0 (es) 1984-05-16
ES8404678A1 (es) 1984-05-16
BR8204328A (pt) 1983-07-19
MW2682A1 (en) 1984-03-14
KR890000768B1 (ko) 1989-04-05
CH647234A5 (en) 1985-01-15
JPH0345064B2 (is) 1991-07-09
KR840000489A (ko) 1984-02-22
PL237634A1 (en) 1984-01-30
ZA825104B (en) 1983-04-27
JPS5824558A (ja) 1983-02-14
GR76177B (is) 1984-08-03
PL138918B1 (en) 1986-11-29

Similar Documents

Publication Publication Date Title
DK154185D0 (da) Fremgangsmaade og apparat til fremstilling af granulater
DK159129C (da) Apparat og fremgangsmaade til hoestning af afgroeder
DK89282A (da) Holder og fremgangsmaade til opsaetning af paneler
DK159672C (da) Fremgangsmaade og apparat til fremstilling af soft-ice
DK153255C (da) Hydrofonkabel og fremgangsmaade til fremstilling af samme
DK521882A (da) Komposition og fremgangsmaade til metalaftraekning
DK149842C (da) Fremgangsmaade til fremstilling af d-camphorat af l-carnitinamid og d-camphorat af d-carnitinamid
DK348582A (da) Fremgangsmaade og anlaeg til braending af kalk
IS2700A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
IS1469B6 (is) Efni afleidd af Tricyclic Pyridine og aðferð til framleiðslu þeirra
DK565981A (da) Kommutator og fremgangsmaade til fremstilling deraf
DK509882A (da) Konstruktionselement og fremgangsmaade til fremstilling af samme
DK149385D0 (da) Apparat og fremgangsmaade til fremstilling af ispinde
IS3344A7 (is) Efni afleidd af pyrimidine og aðferð til framleiðslu þeirra
DK154279A (da) Fremgangsmaade og apparat til paasaetning af letvaegtskapsler af afrivningstypen
DK39281A (da) Fremgangsmaade til fremstilling af 17alfa-acyloxy-5beta-corticoider og 17alfa-acyloxy-5alfa-corticoider
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK271582A (da) Fremgangsmaade og komposition til fremstilling af asbestfrie genstande
DK250278A (da) Fremgangsmaade til fremstilling og udvinding af proteinstoffer
DK205982A (da) Fremgangsmaade og middel til flegmatisering af hydroxy-benzotriazoler hydroxy-oxo-dihydro-benzotriaziner
DK156940C (da) Apparat og anlaeg til adskillelse af faststoffer af indbyrdes forskellige faconer
DK520381A (da) Intermetalliske forbindelser af polymere overgangsmetaloxidalkoxider og fremgangsmaader til fremstilling heraf
IS2742A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
DK127182A (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-(2-phenylacetamido)penicillanater og mellemprodukter herved
DK156509C (da) Fremgangsmaade og indretning til fremstilling af cement